How VABYSMO may help in wet AMD

VABYSMO^® improves vision quickly and delivers a chance for up to 4 months between treatments

After 4 initial monthly doses. Your retina specialist will determine the dosing schedule that is right for you. Scroll down to learn more.

VABYSMO IMPROVES VISION QUICKLY

On average, people gained and maintained 6 letters on an eye chart in 1 year (chart)

On average, people gained and maintained 6 letters on an eye chart over 1 year with VABYSMO, similar to aflibercept.

Even greater results of at least 15 letters were achieved by 20% of people taking VABYSMO, similar to aflibercept.

VABYSMO helped people quickly gain some vision back after just 1 treatment*

Over 95% of people maintained their vision improvement
after 1 year with VABYSMO, similar to aflibercept^†

Over 95% of people
maintained their vision improvement
after 1 year with VABYSMO, similar to aflibercept^†

*After their first treatment, people on average gained 5 letters on an eye chart at 1 month with VABYSMO, similar to aflibercept.

^†Maintained is defined as not losing 15 letters or more.

These results were not controlled for a possible type of statistical analysis error. Conclusions beyond the data shown should not be drawn.

VABYSMO was assessed in 2 clinical studies vs aflibercept with 1329 people who were newly diagnosed with wet AMD.

WITH VABYSMO, YOUR NEXT TREATMENT COULD BE 4 MONTHS AWAY

2-3-4 months between injections (graphic)

Although most people from the clinical trials went 3-4 months between injections, this may not be the experience of all people. Your retina specialist may evaluate your disease differently from the methods used in our trials.

After 4 initial monthly doses to stabilize your vision, your retina specialist may want to scan your eye or give you a vision test. These assessments will help determine if you can extend to 2-, 3-, or 4-month dosing.

VABYSMO gives you back some normalcy. We can plan things further out now and manage the things that come up.

Larry, VABYSMO patient being treated for wet AMD since April 2022

Patient experiences may vary.

A chance for up to 4 months injection-free

Patient experiences may vary.

A chance for up to 4 months injection-free

Patient experiences may vary.

We’re here to help

The Genentech Ophthalmology Support Line makes it easy for you to quickly access the information and support you need.

Just call (833) EYE-GENE/(833) 393-436 3 and one of our representatives will be with you soon. Our representatives are available Monday to Friday, 9 am to 8 pm ET.

There may be options to help you afford VABYSMO. Find out what assistance you might be eligible for.

DISCOVER FINANCIAL SUPPORT

What is VABYSMO?

VABYSMO (faricimab-svoa) is a prescription medicine given by injection into the eye used to treat adults with neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).

Do not receive VABYSMO if you:

Have an infection in or around your eye.
Have active swelling around your eye that may include pain and redness.
Are allergic to VABYSMO or any of the ingredients in VABYSMO.

What is the most important information I should know about VABYSMO?

Injections like the one for VABYSMO can cause an eye infection (endophthalmitis) or separation of layers of the retina (retinal detachment). Call your healthcare provider right away if you have increasing eye pain, vision loss, sensitivity to light, or redness in the white of the eye.
VABYSMO may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs within 60 minutes after receiving the eye injection.
Although not common, VABYSMO patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes (thromboembolic events). In clinical studies for wet AMD during the first year, 7 out of 664 patients treated with VABYSMO reported such an event. In clinical studies for DME from baseline to week 100, 64 out of 1,262 patients treated with VABYSMO reported such an event.

Before receiving VABYSMO, tell your healthcare provider about all of your medical conditions, including if you:

Are pregnant or plan to become pregnant. Based on how VABYSMO interacts with your body, there may be a potential risk to your unborn baby. You should use birth control before your first injection, during your treatment with VABYSMO, and for 3 months after your last dose of VABYSMO.
Are breastfeeding or plan to breastfeed. It is not known if VABYSMO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you receive VABYSMO.
Are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider about every medicine you take.

What should I avoid while receiving VABYSMO?

Your vision may be impaired after receiving an eye injection or after an eye exam. Do not drive or use machinery until your vision has recovered sufficiently.

What are the most common side effects with VABYSMO?

The most common side effects with VABYSMO were cataract and blood on the white of the eye (conjunctival hemorrhage).
These are not all the possible side effects of VABYSMO.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.

Please see the VABYSMO full Prescribing Information for additional Important Safety Information.

VABYSMO® improves vision quickly and delivers a chance for up to 4 months between treatments

A chance for up to 4 months injection-free

A chance for up to 4 months injection-free

We’re here to help

We’re here to help

IMPORTANT SAFETY INFORMATION

VABYSMO^® improves vision quickly and delivers a chance for up to 4 months between treatments